SV119-gold nanocage conjugates: a new platform for targeting cancer cells via sigma-2 receptors

by Wang, Y. C.; Xu, J. B.; Xia, X. H.; Yang, M. X.; Vangveravong, S.; Chen, J. Y.; Mach, R. H.; Xia, Y. N.

We have functionalized the surface of gold nanocages with SV119, a synthetic small molecule specific to sigma-2 receptors, and then demonstrated the capability of this new class of conjugates for targeting cancer cells.